Legal Representation
Attorney
Aral A. Egilmez, Esq.
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 22, 2022 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 21, 2022 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 20, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| May 25, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 25, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 5, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 16, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 16, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 16, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 16, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 16, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Apr 15, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 12, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Therapeutic vaccines
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Vaccine research and development; Conducting early evaluations in the field of new pharmaceuticals; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
THERAPY X INC
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"INC."